The Fundamentals of Antiseizure Medications: A Through Z

Since bromides were first used in 1857 to treat epilepsy, numerous antiseizure medications (ASM) have been developed. Many of these are available for the treatment of epilepsy and status epilepticus today. With so many ASM available, questions arise as to whether all of these medications are needed and when should they be used. As precision medicine begins to play a larger role in determining targeted treatments for specific types of epilepsy, a complete understanding of various medications is needed. Additionally, access to several of these medications can be limited in the United States and are especially limited globally. All these factors can make proper selection of ASM challenging and difficult for clinicians. This review highlights important aspects of older and newer medications, developments in precision medicine for epilepsy, increasing understanding of effective treatments for status epileptics, and a global perspective on ASM availability.

Authors

Institutions

Publication Details

Journal
Epiliepsy currents/Epilepsy currents
Published
2024-10-07
DOI
https://doi.org/10.1177/15357597241281838
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Fundamentals of Antiseizure Medications: A Through Z

David G. Vossler, Timothy E. Welty, Alica M. Goldman, Kristen Park et al.
Epiliepsy currents/Epilepsy currents
Epilepsy research and treatment
article

The Fundamentals of Antiseizure Medications: A Through Z

David G. Vossler, Timothy E. Welty, Alica M. Goldman, Kristen Park, Archana A. Patel, Jacquelyn Bainbridge, Jeannine M. Conway
article en

Abstract

Since bromides were first used in 1857 to treat epilepsy, numerous antiseizure medications (ASM) have been developed. Many of these are available for the treatment of epilepsy and status epilepticus today. With so many ASM available, questions arise as to whether all of these medications are needed and when should they be used. As precision medicine begins to play a larger role in determining targeted treatments for specific types of epilepsy, a complete understanding of various medications is needed. Additionally, access to several of these medications can be limited in the United States and are especially limited globally. All these factors can make proper selection of ASM challenging and difficult for clinicians. This review highlights important aspects of older and newer medications, developments in precision medicine for epilepsy, increasing understanding of effective treatments for status epileptics, and a global perspective on ASM availability.

Epiliepsy currents/Epilepsy currents
Boston Children's Hospital (US), University of Minnesota (US), Harvard University (US), Baylor College of Medicine (US), University of Washington (US), UnityPoint Health (US), University of Colorado Anschutz Medical Campus (US), University of Montana (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 76%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.